600750 江中藥業
按盤價 
23.250 +0.400 (+1.751%) | 2024/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,227,404 | -8.74% | 4,390,102 | 3,885,183 | 2,873,974 | 2,441,452 | |
| 減：營業總成本 | 899,421 | -15.24% | 3,497,962 | 3,229,885 | 2,339,197 | 1,895,961 | |
| 其中:營業成本 | 383,292 | -13.08% | 1,523,006 | 1,384,302 | 1,024,854 | 845,522 | |
| 財務費用 | (21,287) | 71.23% | (59,805) | (27,592) | (22,421) | (13,065) | |
| 資產減值損失 | (8,221) | -- | (8,854) | (112) | (1,380) | (2,301) | |
| 公允價值變動收益 | 620 | -91.35% | (37,108) | 57,098 | 53,613 | (10,661) | |
| 投資收益 | (157) | -55.27% | (2,938) | 4,370 | (2,364) | (5,315) | |
| 其中：對聯營企業和合營企業的投資收益 | (206) | -41.35% | (2,938) | (821) | (3,021) | (8,650) | |
| 營業利潤 | 335,215 | 11.03% | 894,116 | 748,406 | 625,987 | 573,931 | |
| 利潤總額 | 336,055 | 9.66% | 897,134 | 753,280 | 623,140 | 579,395 | |
| 減：所得稅費用 | 51,510 | 10.25% | 130,470 | 106,887 | 92,190 | 89,072 | |
| 淨利潤 | 284,545 | 9.55% | 766,664 | 646,394 | 530,949 | 490,323 | |
| 減：非控股權益 | 17,766 | 3.38% | 58,372 | 48,153 | 25,262 | 16,584 | |
| 股東淨利潤 | 266,780 | 9.99% | 708,292 | 598,241 | 505,687 | 473,739 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.430 | 10.26% | 1.120 | 0.950 | 0.800 | 0.750 | |
| 每股派息 (元) * | -- | -- | 1.300 | 1.150 | 0.870 | 0.270 | |
| 每股淨資產 (元) * | 6.514 | -0.81% | 6.087 | 6.180 | 6.354 | 6.154 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 05/07/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
